Back to Stakeholders
Categories

3 domains / 3 areas / 3 specializations

Government, Policy & Advocacy
Policy Advocacy & ReformDrug Policy Reform Organizations
Care Delivery & Psychedelic Facilitation
Psychedelic Healthcare ImplementationPayer & Reimbursement Stakeholders
Adjunct Industries
Legal, Regulatory & ComplianceRegulatory Affairs

IHPI

Also known as: Ibogaine Healthcare Policy Institute, IHPI, Inc.

United States, United States

IHPI (Ibogaine Healthcare Policy Institute) is a 501(c)(3) nonprofit building policy infrastructure for regulated ibogaine care in the United States. Its work focuses on decision-grade resources for healthcare leaders, including safety and delivery standards, regulatory pathways, reimbursement mechanics, payment/coding roadmaps, coverage criteria, and implementation planning. The organization was founded on 1 January 2026 and is incubated by Delphi.

Reimbursement & Market Access Snapshot

Insurance Payers & Reimbursement Specialists

Service Model

Market Access Advisory

Jurisdiction

National

Coverage

1 country

Last Verified

May 22, 2026

Focus Areas

Coverage Policy DesignPayment Coding PathwaysBudget Impact AnalysisFormulary & Access CriteriaReal-World Evidence for Access

Evidence Requirements

Clinical Efficacy EndpointsLong-Term SafetyCost-EffectivenessBudget ImpactReal-World Evidence

Market Access Notes

IHPI describes payer system infrastructure as a core workstream, including payer-ready economics, coding roadmaps, budget impact logic, benefit design support, and coverage criteria scaffolds for regulated ibogaine treatment.

Verification

Verified

Psychedelic Focus

Explicit Psychedelic Focus

Engagement Status

Active

Primary Access Link

Linked Stakeholders

Delphi

Source Evidence

IHPI website

https://ibogainepolicy.org/

Quick Facts

Type
Non-Profit
Founded
2026
HQ
United States, United States
Website
Visit